These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

544 related items for PubMed ID: 11097743

  • 21. Synergistic induction of apoptosis in breast cancer cells by cotreatment with butyrate and TNF-alpha, TRAIL, or anti-Fas agonist antibody involves enhancement of death receptors' signaling and requires P21(waf1).
    Chopin V, Slomianny C, Hondermarck H, Le Bourhis X.
    Exp Cell Res; 2004 Aug 15; 298(2):560-73. PubMed ID: 15265702
    [Abstract] [Full Text] [Related]

  • 22. p51A (TAp63gamma), a p53 homolog, accumulates in response to DNA damage for cell regulation.
    Katoh I, Aisaki KI, Kurata SI, Ikawa S, Ikawa Y.
    Oncogene; 2000 Jun 22; 19(27):3126-30. PubMed ID: 10871867
    [Abstract] [Full Text] [Related]

  • 23. UCN-01-induced cell cycle arrest requires the transcriptional induction of p21(waf1/cip1) by activation of mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway.
    Facchinetti MM, De Siervi A, Toskos D, Senderowicz AM.
    Cancer Res; 2004 May 15; 64(10):3629-37. PubMed ID: 15150122
    [Abstract] [Full Text] [Related]

  • 24. Induction of p21(CIP1/Waf1) and activation of p34(cdc2) involved in retinoic acid-induced apoptosis in human hepatoma Hep3B cells.
    Hsu SL, Chen MC, Chou YH, Hwang GY, Yin SC.
    Exp Cell Res; 1999 Apr 10; 248(1):87-96. PubMed ID: 10094816
    [Abstract] [Full Text] [Related]

  • 25. Investigation of the role of Bax, p21/Waf1 and p53 as determinants of cellular responses in HCT116 colorectal cancer cells exposed to the novel cytotoxic ruthenium(II) organometallic agent, RM175.
    Hayward RL, Schornagel QC, Tente R, Macpherson JS, Aird RE, Guichard S, Habtemariam A, Sadler P, Jodrell DI.
    Cancer Chemother Pharmacol; 2005 Jun 10; 55(6):577-83. PubMed ID: 15726367
    [Abstract] [Full Text] [Related]

  • 26. Induction of apoptosis by the p53-273L (Arg --> Leu) mutant in HSC3 cells without transactivation of p21Waf1/Cip1/Sdi1 and bax.
    Kaneuchi M, Yamashita T, Shindoh M, Segawa K, Takahashi S, Furuta I, Fujimoto S, Fujinaga K.
    Mol Carcinog; 1999 Sep 10; 26(1):44-52. PubMed ID: 10487521
    [Abstract] [Full Text] [Related]

  • 27. Histone H3 acetylation is associated with reduced p21(WAF1/CIP1) expression by gastric carcinoma.
    Mitani Y, Oue N, Hamai Y, Aung PP, Matsumura S, Nakayama H, Kamata N, Yasui W.
    J Pathol; 2005 Jan 10; 205(1):65-73. PubMed ID: 15586362
    [Abstract] [Full Text] [Related]

  • 28. Adenovirus-mediated expression of p53 or p21 in a papillary serous endometrial carcinoma cell line (SPEC-2) results in both growth inhibition and apoptotic cell death: potential application of gene therapy to endometrial cancer.
    Ramondetta L, Mills GB, Burke TW, Wolf JK.
    Clin Cancer Res; 2000 Jan 10; 6(1):278-84. PubMed ID: 10656459
    [Abstract] [Full Text] [Related]

  • 29. Novel target for induction of apoptosis by cyclo-oxygenase-2 inhibitor SC-236 through a protein kinase C-beta(1)-dependent pathway.
    Jiang XH, Lam SK, Lin MC, Jiang SH, Kung HF, Slosberg ED, Soh JW, Weinstein IB, Wong BC.
    Oncogene; 2002 Sep 05; 21(39):6113-22. PubMed ID: 12203123
    [Abstract] [Full Text] [Related]

  • 30. p53 status does not affect sensitivity of human ovarian cancer cell lines to paclitaxel.
    Debernardis D, Siré EG, De Feudis P, Vikhanskaya F, Valenti M, Russo P, Parodi S, D'Incalci M, Broggini M.
    Cancer Res; 1997 Mar 01; 57(5):870-4. PubMed ID: 9041188
    [Abstract] [Full Text] [Related]

  • 31. [Effects of hepatitis B virus X gene on p21(WAF1) expression through p53-dependent and p53-independent pathways].
    Lin J, Zhu MH, Qu JH, Li FM, Ni CR.
    Ai Zheng; 2004 Jul 01; 23(7):749-55. PubMed ID: 15248906
    [Abstract] [Full Text] [Related]

  • 32. Low concentrations of paclitaxel induce cell type-dependent p53, p21 and G1/G2 arrest instead of mitotic arrest: molecular determinants of paclitaxel-induced cytotoxicity.
    Giannakakou P, Robey R, Fojo T, Blagosklonny MV.
    Oncogene; 2001 Jun 28; 20(29):3806-13. PubMed ID: 11439344
    [Abstract] [Full Text] [Related]

  • 33. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage.
    Seoane J, Le HV, Massagué J.
    Nature; 2002 Oct 17; 419(6908):729-34. PubMed ID: 12384701
    [Abstract] [Full Text] [Related]

  • 34. ING1 represses transcription by direct DNA binding and through effects on p53.
    Kataoka H, Bonnefin P, Vieyra D, Feng X, Hara Y, Miura Y, Joh T, Nakabayashi H, Vaziri H, Harris CC, Riabowol K.
    Cancer Res; 2003 Sep 15; 63(18):5785-92. PubMed ID: 14522900
    [Abstract] [Full Text] [Related]

  • 35. Acute and delayed apoptosis induced by thymidine deprivation correlates with expression of p53 and p53-regulated genes in colon carcinoma cells.
    Harwood FG, Frazier MW, Krajewski S, Reed JC, Houghton JA.
    Oncogene; 1996 May 16; 12(10):2057-67. PubMed ID: 8668331
    [Abstract] [Full Text] [Related]

  • 36. Normal p53 status and function despite the development of drug resistance in human breast cancer cells.
    Wosikowski K, Regis JT, Robey RW, Alvarez M, Buters JT, Gudas JM, Bates SE.
    Cell Growth Differ; 1995 Nov 16; 6(11):1395-403. PubMed ID: 8562478
    [Abstract] [Full Text] [Related]

  • 37. Inhibition of the NF-kappa B transcription factor increases Bax expression in cancer cell lines.
    Bentires-Alj M, Dejardin E, Viatour P, Van Lint C, Froesch B, Reed JC, Merville MP, Bours V.
    Oncogene; 2001 May 17; 20(22):2805-13. PubMed ID: 11420692
    [Abstract] [Full Text] [Related]

  • 38. Induction of apoptosis in breast cancer cells by TPA.
    Li Y, Bhuiyan M, Mohammad RM, Sarkar FH.
    Oncogene; 1998 Dec 03; 17(22):2915-20. PubMed ID: 9879997
    [Abstract] [Full Text] [Related]

  • 39. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis.
    el-Deiry WS, Harper JW, O'Connor PM, Velculescu VE, Canman CE, Jackman J, Pietenpol JA, Burrell M, Hill DE, Wang Y.
    Cancer Res; 1994 Mar 01; 54(5):1169-74. PubMed ID: 8118801
    [Abstract] [Full Text] [Related]

  • 40. Nature of G1/S cell cycle checkpoint defect in ataxia-telangiectasia.
    Khanna KK, Beamish H, Yan J, Hobson K, Williams R, Dunn I, Lavin MF.
    Oncogene; 1995 Aug 17; 11(4):609-18. PubMed ID: 7651723
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.